Shenzhen Chipscreen Biosciences (688321.SH): The drug CS08399 has obtained a notification of approval for clinical trials.

16:48 13/03/2026

Weino Biotechnology (688321.SH) announced that its wholly-owned subsidiary, Chengdu Weino Pharmaceuticals Co., Ltd., recently received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration, allowing the company's product CS08399 tablets to conduct clinical trials. Indications: Intended for the treatment of solid tumors and lymphomas with methylthioadenosine phosphorylase (MTAP) deficiency.

Shenzhen Chipscreen Biosciences (688321.SH) announced that its wholly-owned subsidiary, Chengdu Microchip Pharmaceutical Co., Ltd., has recently received a "Notice of Approval for Clinical Trial of Drugs" issued by the National Medical Products Administration, approving the clinical trial of the company's product CS08399 tablets. Indications: intended for the treatment of solid tumors and lymphomas with methylthioadenosine phosphorylase (MTAP) deficiency.

Industrial: How do high oil prices affect US inflation and Federal Reserve actions?

EB SECURITIES: AI inflation is giving birth to a new cycle, and the price increase of optical fiber and copper-clad laminate is driving the growth of industry companies.

Microsoft Corporation (MSFT.US) Azure takes the lead and becomes the first global cloud service provider to begin validating the NVIDIA Corporation Vera Rubin NVL72 system.

Industrial: How do high oil prices affect US inflation and Federal Reserve actions?

EB SECURITIES: AI inflation is giving birth to a new cycle, and the price increase of optical fiber and copper-clad laminate is driving the growth of industry companies.

Microsoft Corporation (MSFT.US) Azure takes the lead and becomes the first global cloud service provider to begin validating the NVIDIA Corporation Vera Rubin NVL72 system.